e-learning
resources
Virtual 2021
06.09.2021
New insights into the pathophysiology and prognosis of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD
A. Kharat (Montréal (QC), Canada), M. Girard (Montréal (QC), Canada), B. Dube (Montréal (QC), Canada)
Source:
Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Session:
New insights into the pathophysiology and prognosis of COPD
Session type:
Oral Presentation
Number:
2559
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kharat (Montréal (QC), Canada), M. Girard (Montréal (QC), Canada), B. Dube (Montréal (QC), Canada). Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD. 2559
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
The physiology of breathlessness
Related content which might interest you:
Ultrasonographic assessment of diaphragm dysfunction in acute exacerbations of COPD
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Factors associated with poor prognostic outcome in acute exacerbation of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Impact of patient nutritional status on acute exacerbation of COPD
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD
Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017
Year: 2017
The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
The relationship of exacerbations and lung function decline to radiologic characteristics in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Cardiac biomarkers and outcomes of COPD exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept